Insider Transactions in Q1 2022 at Arena Pharmaceuticals Inc (ARNA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2022
|
Robert Lisicki EVP, Chief Commercial Officer |
SELL
Other acquisition or disposition
|
Direct |
37,563
-49.61%
|
-
|
|
Mar 11
2022
|
Vincent Aurentz Executive VP and CBO |
SELL
Other acquisition or disposition
|
Direct |
55,964
-57.81%
|
-
|
|
Mar 11
2022
|
Joan Schmidt EVP, General Counsel & Sec |
SELL
Other acquisition or disposition
|
Direct |
36,287
-48.73%
|
-
|
|
Mar 11
2022
|
Amit Munshi President and CEO |
SELL
Other acquisition or disposition
|
Direct |
114,897
-41.78%
|
-
|
|
Mar 11
2022
|
Laurie Stelzer EVP & Chief Financial Officer |
SELL
Other acquisition or disposition
|
Direct |
37,208
-49.37%
|
-
|
|
Mar 11
2022
|
Douglas J. Manion EVP Research & Development |
SELL
Other acquisition or disposition
|
Direct |
36,462
-70.57%
|
-
|
|
Mar 11
2022
|
Nawal Ouzren Director |
SELL
Other acquisition or disposition
|
Direct |
4,555
-59.77%
|
-
|
|
Mar 11
2022
|
Jayson Donald Alexander Dallas Director |
SELL
Other acquisition or disposition
|
Direct |
7,152
-78.56%
|
-
|
|
Mar 11
2022
|
Steven J Schoch Director |
SELL
Other acquisition or disposition
|
Direct |
4,600
-100.0%
|
-
|
|
Mar 11
2022
|
Garry Arthur Neil Director |
SELL
Other acquisition or disposition
|
Direct |
11,217
-86.33%
|
-
|
|
Mar 11
2022
|
Jennifer Jarrett Director |
SELL
Other acquisition or disposition
|
Direct |
11,217
-86.33%
|
-
|
|
Mar 11
2022
|
Katharine Knobil Director |
SELL
Other acquisition or disposition
|
Direct |
6,821
-71.54%
|
-
|
|
Mar 11
2022
|
Kieran Gallahue Director |
SELL
Other acquisition or disposition
|
Direct |
9,283
-56.01%
|
-
|
|
Mar 11
2022
|
Kieran Gallahue Director |
SELL
Other acquisition or disposition
|
Indirect |
3,628
-100.0%
|
-
|
|
Mar 11
2022
|
Oliver Fetzer Director |
SELL
Other acquisition or disposition
|
Direct |
9,692
-57.87%
|
-
|
|
Mar 11
2022
|
Tina Susan Nova Director |
SELL
Other acquisition or disposition
|
Direct |
20,843
-92.64%
|
-
|
|
Mar 08
2022
|
Amit Munshi President and CEO |
SELL
Bona fide gift
|
Direct |
10,500
-8.37%
|
$1,029,000
$98.51 P/Share
|
|
Jan 03
2022
|
Vincent Aurentz Executive VP and CBO |
BUY
Grant, award, or other acquisition
|
Direct |
21,462
+28.02%
|
-
|
|
Jan 03
2022
|
Robert Lisicki EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,462
+36.36%
|
-
|
|
Jan 03
2022
|
Laurie Stelzer EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,462
+37.11%
|
-
|
|
Jan 03
2022
|
Amit Munshi President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
85,847
+40.64%
|
-
|
|
Jan 03
2022
|
Douglas J. Manion EVP Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
21,462
+37.05%
|
-
|
|
Jan 03
2022
|
Joan Schmidt EVP, General Counsel & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
21,462
+37.31%
|
-
|